Approach to acute renal failure in biopsy proven myeloma cast nephropathy: Is there still a role for plasmapheresis?

Kidney International

Volumn 74, Issue 7, 2008, Pages 956-961

  Pillon, Luana ^a,b,d   Sweeting, Raeshell S ^a,b   Arora, Avi ^a,b   Notkin, Alicia ^a,b   Ballard, Harold S ^a,b   Wieczorek, Rosemary L ^a,b   Leung, Nelson ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MAYO CLINIC   (United States)

^d BELLEVUE HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; CREATININE; DEXAMETHASONE; IMMUNOGLOBULIN A; IPRATROPIUM BROMIDE; LISINOPRIL; SALBUTAMOL; SULFOSALICYLIC ACID; THALIDOMIDE;

ACUTE KIDNEY FAILURE; AGED; ANAMNESIS; ARTICLE; BONE MARROW BIOPSY; CANCER STAGING; CASE REPORT; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DRUG WITHDRAWAL; ECHOGRAPHY; EMPHYSEMA; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOGLOBULIN BLOOD LEVEL; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY PARENCHYMA; KIDNEY VEIN; LABORATORY TEST; MACROCYTIC ANEMIA; MALE; MULTIPLE MYELOMA; MYELOMA CAST NEPHROPATHY; NEUROLOGIC EXAMINATION; OUTPATIENT DEPARTMENT; PERIPHERAL EDEMA; PERIPHERAL NEUROPATHY; PHYSICAL EXAMINATION; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEIN ELECTROPHORESIS; PROTEIN URINE LEVEL; PROTEINURIA; TREATMENT WITHDRAWAL; VASCULAR PATENCY;

EID: 51849153387     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.138     Document Type: Article

References (26)

1. Kyle RA, Gertz MA, Witzig TE et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 2003; 78: 21-33.
2. Gertz MA, Lacy MQ, Dispenzieri A et al. Impact of age and serum creatinine value on outcome after autologous blood stem cell transplantation for patients with multiple myeloma. Bone Marrow Transplant 2007; 39: 605-611.
3. Kyle RA. Multiple myeloma: review of 869 cases. Mayo Clin Proc 1975; 50: 29-40.
4. Rayner HC, Haynes AP, Thompson JR et al. Perspectives in multiple myeloma: survival, prognostic factors and disease complications in a single centre between 1975 and 1988. Q J Med 1991; 79: 517-525.
5. Alexanian R, Barlogie B, Dixon D. Renal failure in multiple myeloma. Pathogenesis and prognostic implications. Arch Intern Med 1990; 150: 1693-1695.
6. Blade J, Fernandez-Llama P, Bosch F et al. Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution. Arch Intern Med 1998; 158: 1889-1893.
7. Montseny JJ, Kleinknecht D, Meyrier A et al. Long-term outcome according to renal histological lesions in 118 patients with monoclonal gammopathies. Nephrol Dial Transplant 1998; 13: 1438-1445.
8. Ivanyi B. Frequency of light chain deposition nephropathy relative to renal amyloidosis and Bence Jones cast nephropathy in a necropsy study of patients with myeloma. Arch Pathol Lab Med 1990; 114: 986-987.
9. Fogo A, Qureshi N, Horn RG. Morphologic and clinical features of fibrillary glomerulonephritis versus immunotactoid glomerulopathy [see comment] [erratum appears in Am J Kidney Dis 1993 Nov;22(5):757]. Am J Kidney Dis 1993; 22: 367-377.
10. Lin J, Markowitz GS, Valeri AM et al. Renal monoclonal immunoglobulin deposition disease: the disease spectrum. J Am Soc Nephrol 2001; 12: 1482-1492.
11. Herrera GA, Joseph L, Gu X et al. Renal pathologic spectrum in an autopsy series of patients with plasma cell dyscrasia [see comment]. Arch Pathol Lab Med 2004; 128: 875-879.
12. Paueksakon P, Revelo MP, Horn RG et al. Monoclonal gammopathy: significance and possible causality in renal disease. Am J Kidney Dis 2003; 42: 87-95.
13. Buxbaum J, Gallo G. Nonamyloidotic monoclonal immunoglobulin deposition disease. Light-chain, heavy-chain, and light- and heavy-chain deposition diseases. Hematol Oncol Clin North Am 1999; 13: 1235-1248.
14. Bouvet JP, Frot JC, Ducaylar A et al. [Gammopathies with oligoclonal electrophoretic patterns. Incidence, immunochemical nature and association with neoplastic pathology]. Presse Med 1983; 12: 2511-2514.
15. Sanders PW, Herrera GA, Chen A et al. Differential nephrotoxicity of low molecular weight proteins including Bence Jones proteins in the perfused rat nephron in vivo. J Clin Invest 1988; 82: 2086-2096.
16. Leboulleux M, Lelongt B, Mougenot B et al. Protease resistance and binding of Ig light chains in myeloma-associated tubulopathies. Kidney Int 1995; 48: 72-79.
17. Clark AD, Shetty A, Soutar R. Renal failure and multiple myeloma: pathogenesis and treatment of renal failure and management of underlying myeloma. Blood Rev 1999; 13: 79-90.
18. Kyle RA, Beard CM, O'Fallon WM et al. Incidence of multiple myeloma in Olmsted County, Minnesota: 1978 through 1990, with a review of the trend since 1945. J Clin Oncol 1994; 12: 1577-1583.
19. Abbott KC, Agodoa LY. Multiple myeloma and light chain-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival. Clin Nephrol 2001; 56: 207-210.
20. Sanders PW, Booker BB. Pathobiology of cast nephropathy from human Bence Jones proteins. J Clin Invest 1992; 89: 630-639.
21. Winearls CG. Acute myeloma kidney. Kidney Int 1995; 48: 1347-1361.
22. Pasquali S, Casanova S, Zucchelli A et al. Long-term survival patients with acute and severe renal failure due to multiple myeloma. Clin Nephrol 1990; 34: 247-254.
23. Zucchelli P, Pasquali S, Cagnoli L et al. Controlled plasma exchange trial in acute renal failure due to multiple myeloma. Kidney Int 1988; 33: 1175-1180.
24. Johnson WJ, Kyle RA, Pineda AA et al. Treatment of renal failure associated with multiple myeloma. Plasmapheresis, hemodialysis, and chemotherapy. Arch Intern Med 1990; 150: 863-869.
25. Durie BG, Kyle RA, Belch A et al. Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation [erratum appears in Hematol J 2004;5(3):285]. Hematol J 2003; 4: 379-398.
26. Clark WF, Stewart AK, Rock GA et al. Plasma exchange when myeloma presents as acute renal failure: a randomized, controlled trial [see comment] [summary for patients in Ann Intern Med 2005 Dec 6;143(11):I20; PMID: 16330784]. Ann Intern Med 2005; 143: 777-784.